Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

An update on the regulatory mechanisms of NLRP3 inflammasome activation

Seungwha PaikDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, KoreaJin Kyung KimDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, KoreaPrashanta SilwalDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, KoreaChihiro SasakawaMedical Mycology Research Center, Chiba University, Chiba, JapanEun‐Kyeong JoDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea. [email protected]
2021en
ABI

Аннотация

The NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome is a multiprotein complex involved in the release of mature interleukin-1β and triggering of pyroptosis, which is of paramount importance in a variety of physiological and pathological conditions. Over the past decade, considerable advances have been made in elucidating the molecular mechanisms underlying the priming/licensing (Signal 1) and assembly (Signal 2) involved in NLRP3 inflammasome activation. Recently, a number of studies have indicated that the priming/licensing step is regulated by complicated mechanisms at both the transcriptional and posttranslational levels. In this review, we discuss the current understanding of the mechanistic details of NLRP3 inflammasome activation with a particular emphasis on protein-protein interactions, posttranslational modifications, and spatiotemporal regulation of the NLRP3 inflammasome machinery. We also present a detailed summary of multiple positive and/or negative regulatory pathways providing upstream signals that culminate in NLRP3 inflammasome complex assembly. A better understanding of the molecular mechanisms underlying NLRP3 inflammasome activation will provide opportunities for the development of methods for the prevention and treatment of NLRP3 inflammasome-related diseases.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0